The iBIONICS Diamond Eye

Delivering functional central vision, image perception and increased patient independence

The Costs

Over 50 million people worldwide, born with sight, are afflicted with Age-Related Macular Degeneration or Retinitis Pigmentosa leading to blindness. In 2007, in Canada alone, the cost of blindness was $15.8 billion.

Worldwide Data

2015: 50 Million People Living with Degenerative Retina Disease

⬇︎ 1/4 of the World’s Blind Population

2020: 196 Million People Living with Degenerative Retina Disease

⬇︎ Societal Cost of Blindness = $670 Billion

The iBIONICS Diamond Eye: A Visionary Solution

Developed at the University of Melbourne under Bionic Vision Australia, the iBIONICS Diamond Eye restores vision enabling the blind to regain autonomy, recognize faces and read large print. The iBIONICS Diamond Eye uses diamond electrodes to stimulate the retina, sending messages to the brain perceived as light. This leading technology designed to return autonomy and partial vision to the blind is supported by a state-of-the-art wireless solution for implantable bionic devices developed in Canada.

4 Key Benefits


High Visual Acuity and Reliability

Cutting-edge Patented Nitrogen Doped Diamond Electrode and Diamond Packaging Technology


Wireless Power Harvesting and Video Data Recovery in Retinal Implant

Diminished Risk of Infection

Contact us today about iBIONICS